A Fatal Neurological Disease With No Treatment Just Got Its First Drug
The FDA's September 3 approval of Zanvastro marks the first disease-modifying treatment for Alexander disease, an ultra-rare neurological disorder affecting roughly one in one million people. The drug targets the genetic root

Follow